Comorbidities, medication use, and overall survival in eight cancers: a multinational cohort study of 1.7 million patients across Europe LANCET REG HEALTH-EU
Allo-HCT with post-transplant cyclophosphamide in older adults: similar safety and a viable option compared to younger adults Front Immunol
In Vitro Evidence of Therapy-Induced Suppression of Prothrombotic and Proinflammatory Phenotypes in Severe COVID-19 THROMB HAEMOSTASIS
m-EASIX (better than EASIX) predicts severe CAR T-cell toxicities, worse overall survival, and discriminates cytokine release syndrome from sepsis Front Immunol
European Expert Recommendations on Teclistamab Management for Relapsed or Refractory Multiple Myeloma CL LYMPH MYELOM LEUK